Ethypharm is a European pharmaceutical company employing 1,700 professionals across Europe and China. Specializing in comprehensive Contract Development and Manufacturing (CDMO) services, Ethypharm supports the entire drug development process. This includes API sourcing, regulatory strategy definition, formulation development, pilot and clinical batch manufacturing, stability studies, and analytical method development and validation.

Ethypharm excels in producing sterile forms (ampoules, pre-filled syringes, IV bags, vials, lyophilized products), oral medications, and complex solid dosage forms. They handle a wide range of APIs, including conventional, high-potency, narcotics, and controlled substances.

Choosing Ethypharm as your CDMO partner grants you access to advanced technologies such as Flashtab, taste masking, nanosizing, Multicaps, transmucosal, and orodispersible technologies. These innovations enable the development of formulations that meet the evolving needs of patients and the pharmaceutical industry.

Type of Drugs Manufactured:

Small Molecule;Medical Devices

CDMO Services:

Drug Product Formulation (FDF);Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

3-5

High Potent Products capabilities:

OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);GMP;PMDA (Japan);Health Canada;ANVISA (Brazil)

Manufacturing Technologies:

Cartridges;Liquids;Lyophilized amps/vials;Pre-Filled Syringes (PFS);Solids;Sterile Ampoules;Sterile Vials

Ethypharm actively seeks licensing, distribution, and acquisition opportunities, particularly in hospital injectables, CNS, and internal medicine. For further information, visit ethypharm.com.